Background
Methods
Meta-analysis
Overlap of ERα and GATA3 (4 or more studies) | |||
---|---|---|---|
ERα = 257, GATA3 = 194, OVERLAP = 108 | |||
ERα
|
GATA3
| ||
GATA3 |
48%
| 100% | GATA binding protein 3 |
ESR1 | 100% |
67%
| estrogen receptor 1 (estrogen receptor alpha) |
XBP1 |
38%
|
52%
| X-box binding protein 1 |
FOXA1 |
33%
|
52%
| forkhead box A1 |
FOXC1 | 19% | 24% | forkhead box C1 |
TFF1 |
33%
|
52%
| trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in) [pS2] |
TFF3 |
38%
|
67%
| trefoil factor 3 (intestinal) |
NRIP1 | 19% | 19% | nuclear receptor interacting protein 1 (RIP140) |
BCL2 |
43%
|
67%
| B-cell CLL/lymphoma 2 |
ACADSB |
38%
|
48%
| acyl-Coenzyme A dehydrogenase, short/branched chain |
LAF4 |
43%
|
38%
| lymphoid nuclear protein related to AF4 |
COX6C |
38%
|
33%
| cytochrome c oxidase subunit VIc |
FBP1 |
38%
|
33%
| fructose-1,6-bisphosphatase 1 |
IGF1R |
38%
|
33%
| insulin-like growth factor 1 receptor |
IRS1 |
33%
|
33%
| insulin receptor substrate 1 |
CELSR2 |
38%
|
38%
| cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila) |
LRBA |
38%
|
38%
| LPS-responsive vesicle trafficking, beach and anchor containing |
NAT1 |
33%
|
57%
| N-acetyltransferase 1 (arylamine N-acetyltransferase) |
SCNN1A |
38%
|
57%
| sodium channel, nonvoltage-gated 1 alpha |
DNAJC12 |
33%
|
48%
| DnaJ (Hsp40) homolog, subfamily C, member 12 |
RAB31 |
38%
| 19% | RAB31, member RAS oncogene family |
RABEP1 |
33%
|
43%
| rabaptin, RAB GTPase binding effector protein 1 |
SELENBP1 |
33%
|
33%
| selenium binding protein 1 |
FAAH |
38%
|
33%
| fatty acid amide hydrolase |
TNFSF10 |
38%
|
33%
| tumor necrosis factor (ligand) superfamily, member 10 |
SLC22A18 |
33%
| 24% | solute carrier family 22 (organic cation transporter), member 1 |
SLC39A6 |
38%
|
57%
| solute carrier family 39 (zinc transporter), member 6 (Estrogen regulated protein LIV-1) |
SLC40A1 |
33%
| 19% | solute carrier family 40 (iron-regulated transporter), member 1 |
SLC9A3R1 | 19% |
43%
| solute carrier family 9 (sodium/hydrogen exchanger), isoform 3 regulator 1 |
SIAH2 |
33%
|
33%
| seven in absentia homolog 2 (Drosophila) |
SERPINA3 |
38%
| 24% | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
SERPINA5 |
33%
| 19% | serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), 5 |
SERPINA6 | 19% | 24% | serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), 6 |
ERBB3 |
33%
| 19% | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
ERBB4 | 19% |
48%
| v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
IL6ST | 24% |
38%
| interleukin 6 signal transducer (gp130, oncostatin M receptor) |
KIAA0040 | 24% | 24% | KIAA0040 protein |
KIAA0303 |
33%
|
43%
| Similar to Mouse serine/threonine protein kinase MAST205 |
KIAA0882 | 19% | 19% | KIAA0882 protein |
ITPR1 | 24% |
33%
| inositol 1,4,5-triphosphate receptor, type 1 |
INPP4B | 24% |
43%
| inositol polyphosphate-4-phosphatase, type II, 105kDa |
JMJD2B | 24% |
48%
| jumonji domain containing 2B |
C10orf116 | 24% |
52%
| chromosome 10 open reading frame 116 |
ANXA9 | 19% |
43%
| annexin A9 |
AR | 19% |
33%
| androgen receptor (dihydrotestosterone receptor; Kennedy disease) |
CCND1 | 19% |
48%
| cyclin D1 (PRAD1: parathyroid adenomatosis 1) |
CCNG2 | 19% | 24% | cyclin G2 |
CA12 | 19% |
38%
| carbonic anhydrase XII |
CACNA1D | 19% |
33%
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CACNA2D2 | 19% |
43%
| calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
DNALI1 | 24% |
43%
| dynein, axonemal, light intermediate polypeptide 1 |
AGR2 | 19% |
33%
| anterior gradient 2 homolog (Xenepus laevis) |
GFRA1 | 33% |
48%
| GDNF family receptor alpha 1 |
HPN | 19% |
43%
| hepsin (transmembrane protease, serine 1) |
GREB1 | 19% |
38%
| GREB1 protein |
MAPT | 19% |
38%
| microtubule-associated protein tau |
MLPH | 24% |
33%
| melanophilin |
KRT18 | 24% |
33%
| keratin 18 |
PTPRT | 24% |
48%
| protein tyrosine phosphatase, receptor type, T |
STC2 | 24% |
33%
| stanniocalcin 2 |
SCUBE2 |
33%
| 24% | CEGP1 protein |
PTGER3 |
33%
| 24% | prostaglandin E receptor 3 (subtype EP3) |
PDCD4 |
33%
| 24% | programmed cell death 4 (neoplastic transformation inhibitor) |
MUC1 |
33%
| 29% | mucin 1, transmembrane |
NPY1R |
33%
| 29% | neuropeptide Y receptor Y1 |
FLJ20366 |
38%
| 24% | hypothetical protein FLJ20366 |
TLE3 |
33%
| 29% | transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
13CDNA73 | 24% | 29% | hypothetical protein CG003 |
AGTR1 | 24% | 29% | Angiotensin II receptor, type 1 |
ASAH1 | 24% | 29% | N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
BF | 24% | 24% | B-factor, properdin |
ENPP1 | 24% | 29% | ectonucleotide pyrophosphatase/phosphodiesterase 1 |
QDPR | 24% | 29% | quinoid dihydropteridine reductase |
C9orf116 | 19% | 29% | chromosome 9 open reading frame 116 |
CYFIP2 | 19% | 29% | cytoplasmic FMR1 interacting protein 2 |
GRIA2 | 19% | 29% | glutamate receptor, ionotropic, AMPA 2 |
GSTM3 | 19% | 29% | Glutathione S-transferase M3 (brain) |
ACOX2 | 19% | 29% | acyl-Coenzyme A oxidase 2, branched chain |
LRIG1 | 19% | 29% | leucine-rich repeats and immunoglobulin-like domains 1 |
PLAT | 19% | 29% | plasminogen activator, tissue |
MAGED2 | 19% | 29% | Melanoma antigen family D, 2 |
THRAP2 | 19% | 29% | thyroid hormone receptor associated protein 2 |
MSX2 | 24% | 24% | msh homeo box homolog 2 (Drosophila) |
UGCG | 24% | 24% | UDP-glucose ceramide glucosyltransferase |
ALCAM | 19% | 24% | activated leukocyte cell adhesion molecule |
ALDH4A1 | 19% | 24% | aldehyde dehydrogenase 4 family, member A1 |
ABCA3 | 24% | 19% | ATP-binding cassette, sub-family A (ABC1), member 3 |
LOC51760 | 19% | 24% | B/K protein |
PRSS23 | 19% | 24% | protease, serine, 23 |
RHOH | 24% | 19% | ras homolog gene family, member H |
TFAP2B | 19% | 24% | transcription factor AP-2 beta (activating enhancer binding protein 2 beta) |
WFDC2 | 24% | 19% | WAP four-disulfide core domain 2 |
ANGPTL1 | 19% | 19% | angiopoietin-like 1 |
BCAS1 | 19% | 19% | breast carcinoma amplified sequence 1 |
CYP2B6 | 19% | 19% | cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6 |
EML2 | 19% | 19% | echinoderm microtubule associated protein like 2 |
FLNB | 19% | 19% | filamin B, beta (actin binding protein 278) |
GPR160 | 19% | 19% | G protein-coupled receptor 160 |
LU | 19% | 19% | Lutheran blood group (Auberger b antigen included) |
MRPS30 | 19% | 19% | mitochondrial ribosomal protein S30 |
PTE2B | 19% | 19% | peroxisomal acyl-CoA thioesterase 2B |
RERG | 19% | 19% | RAS-like, estrogen-regulated, growth inhibitor |
RNASE4 | 19% | 19% | ribonuclease, RNase A family, 4 |
RNF110 | 19% | 19% | polycomb group ring finger 2 (MEL-18) |
SEMA3C | 19% | 19% | sema domain, immunoglobulin domain (Ig), short basic domain, (semaphorin) 3C |
SULT2B1 | 19% | 19% | sulfotransferase family, cytosolic, 2B, member 1 |
TPBG | 19% | 19% | trophoblast glycoprotein |
TPD52 | 19% | 19% | tumor protein D52 |
KAL1 | 19% | 19% | Kallmann syndrome 1 sequence |
Reporter gene assays
Results and Discussion
GATA3 Oncomine | ERα Oncomine | |
---|---|---|
ESR1 | ✔ | ✔ |
GATA3 | ✔ | ✔ |
TFF1 | ✔ | ✔ |
TFF3 | ✔ | ✔ |
FOXA1 | ✔ | ✔ |
XBP1 | ✔ | ✔ |
IL6ST | ✔ | ✔ |
KRT18 | ✔ | ✔ |
AR | ✔ | ✔ |
BCL2 | ✔ | ✔ |
CCND1 | ✔ | ✔ |
RERG | ✔ | ✔ |
ERBB4 | ✔ | ✔ |
NAT1 | ✔ | ✔ |
SLC39A6 | ✔ | ✔ |
DNAJC12 | ✔ | ✔ |
HPN | ✔ | ✔ |
CYP2B6 | ✔ | ✔ |
CA12 | ✔ | ✔ |
STC2 | ✔ | ✔ |
ACADSB | ✔ | ✔ |
LRBA | ✔ | ✔ |
PTPRT | ✔ | ✔ |
SULT2B1 | ✔ | ✔ |
MYB | ✔ | ✔ |
SEMA3B | ✔ | ✔ |
RET | ✔ | ✔ |
SLC7A2 | ✔ | ✔ |
RABEP1 | ✔ | |
IGFBP4 | ✔ | |
CGA | ✔ | |
GJA1 | ✔ | |
PGR | ✔ | |
RARRES | ✔ | |
BBC3 | ✔ | |
LOC255743 | ✔ |
ERα ChIP-chip: GATA3 Oncomine | ERα ChIP-chip: ERα Oncomine |
---|---|
ABCA3
|
ABCA3
|
ALDH3B2 |
ANXA9
|
ANXA9
| BTRC |
EPS8 | C2 |
ESR1
| CYP51A1 |
FLJ20152 |
ESR1
|
FOXA1
| FLJ13710 |
GREB1
|
FOXA1
|
GTF2H2 |
GREB1
|
LOC51760
| KCNAB2 |
MGC11242
|
LOC51760
|
MGP | MB |
NAV3 |
MGC11242
|
NQO1 | MSP |
PDZK1 |
SEMA3B
|
PHF15 |
SLC27A2
|
RTN1 |
SLC7A2
|
SEMA3B
| STARD10 |
SLC27A2
|
STK39
|
SLC7A2
|
TFF1
|
SLC7A8 |
TFF3
|
STARD10
|
NRIP1
|
STK39
| RUNX1 |
TFF1
| |
TFF3
| |
TOMM40 | |
NRIP1
|